Literature DB >> 12062312

Energy metabolism and expression of uncoupling proteins 1, 2, and 3 after 21 days of recovery from intracerebroventricular mouse leptin in rats.

P Scott Gullicksen1, William P Flatt, Roger G Dean, Diane L Hartzell, Clifton A Baile.   

Abstract

Animals tend to maintain a lower body weight for an extended period after leptin administration has ended. This may be due to an enhancement of metabolic rate that persists after treatment withdrawal. Our objectives were to determine the period of leptin influence, when injected intracerebroventricularly (icv), on food intake, body weight, and energy expenditure. Additionally, the relationship between expressions of UCP1, UCP2, and UCP3 in different adipose tissues and heat production (HP) was assessed. Twenty-four adult male Sprague-Dawley rats were injected intracerebroventricularly with either 10 g mouse leptin or 10 l vehicle once per day for 4 days. At 24 h after the last injection, one group was killed while the other was placed in calorimetry chambers and monitored for 21 days of recovery. Leptin-injected rats exhibited an overshoot of food intake and respiratory quotient (RQ) during recovery, but body weight remained significantly lower up to 6 days. HP decreased in both groups over time but remained higher in the leptin group through recovery. However, retained energy (RE) was significantly greater than control for about 8 days. Overall, UCP expression was reduced at the end of recovery in parallel with the decline in HP. Brown adipose tissue (BAT) was the most responsive to leptin administration by dramatically changing UCP1 and UCP3 mRNA levels. Our data show that leptin has extended effects on energy expenditure but relieves control on food intake and RQ after treatment withdrawal. This translated into a reduced positive energy balance that slowed body weight recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062312     DOI: 10.1016/s0031-9384(02)00652-2

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  7 in total

1.  Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve.

Authors:  Jonathan German; Francis Kim; Gary J Schwartz; Peter J Havel; Christopher J Rhodes; Michael W Schwartz; Gregory J Morton
Journal:  Endocrinology       Date:  2009-07-02       Impact factor: 4.736

2.  Rapid onset and reversal of peripheral and central leptin resistance in rats offered chow, sucrose solution, and lard.

Authors:  John W Apolzan; Ruth B S Harris
Journal:  Appetite       Date:  2012-09-26       Impact factor: 3.868

3.  In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue.

Authors:  Miles E Matsen; Joshua P Thaler; Brent E Wisse; Stephan J Guyenet; Thomas H Meek; Kayoko Ogimoto; Alex Cubelo; Jonathan D Fischer; Karl J Kaiyala; Michael W Schwartz; Gregory J Morton
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-05       Impact factor: 4.310

4.  Deletion of inducible nitric-oxide synthase in leptin-deficient mice improves brown adipose tissue function.

Authors:  Sara Becerril; Amaia Rodríguez; Victoria Catalán; Neira Sáinz; Beatriz Ramírez; María Collantes; Iván Peñuelas; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

5.  Leptin-induced increase in body fat content of rats.

Authors:  Ruth B S Harris
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

Review 6.  Functional Relationship between Leptin and Nitric Oxide in Metabolism.

Authors:  Sara Becerril; Amaia Rodríguez; Victoria Catalán; Beatriz Ramírez; Xabier Unamuno; Piero Portincasa; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Nutrients       Date:  2019-09-06       Impact factor: 5.717

Review 7.  Leptin as a key regulator of the adipose organ.

Authors:  Catalina Picó; Mariona Palou; Catalina Amadora Pomar; Ana María Rodríguez; Andreu Palou
Journal:  Rev Endocr Metab Disord       Date:  2021-09-14       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.